This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hodge, L. M.
Right arrow Articles by Simecka, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hodge, L. M.
Right arrow Articles by Simecka, J. W.

 Previous Article  |  Next Article 

Infection and Immunity, April 2001, p. 2328-2338, Vol. 69, No. 4
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.4.2328-2338.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization

Lisa M. Hodge,1 Mariarosaria Marinaro,2 Harlan P. Jones,1 Jerry R. McGhee,2 Hiroshi Kiyono,2,3,4 and Jerry W. Simecka1,*

Department of Molecular Biology and Immunology, University of North Texas Health Science Center in Fort Worth, Fort Worth, Texas 761071; Department of Microbiology and Immunobiology Vaccine Center2 and Department of Oral Biology,4 University of Alabama at Birmingham, Birmingham, Alabama 35294; and Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan3

Received 18 October 2000/Returned for modification 21 November 2000/Accepted 13 January 2001

The purpose of the present study was to determine the extent of immunologic responses, particularly immunopathologic responses, within the upper and lower respiratory tracts after intranasal immunization using the mucosal adjuvant cholera toxin (CT). BALB/c mice were nasally immunized with influenza virus vaccine combined with CT. The inclusion of the mucosal adjuvant CT clearly enhanced generation of antibody responses in both the nasal passages and lungs. After nasal immunization, antigen-specific immunoglobulin A (IgA) antibody-forming cells dominated antibody responses throughout the respiratory tract. However, IgG responses were significant in lungs but not in nasal passages. Furthermore, parenteral immunization did not enhance humoral immunity in the upper respiratory tract even after a nasal challenge, whereas extrapulmonary lymphoid responses enhanced responses in the lung. After nasal immunization, inflammatory reactions, characterized by mononuclear cell infiltration, developed within the lungs of mice but not in nasal passages. Lowering dosages of CT reduced, but did not eliminate, these adverse reactions without compromising adjuvancy. Serum IgE responses were also enhanced in a dose-dependent manner by inclusion of CT. In summary, there are differences in the generation of humoral immunity between the upper respiratory tract and the lung. As the upper respiratory tract is in a separate compartment of the immune system from that stimulated by parenteral immunization, nasal immunization is an optimal approach to generate immunity throughout the respiratory tract. Despite the promise of nasal immunization, there is also the potential to develop adverse immunopathologic reactions characterized by pulmonary airway inflammation and IgE production.

* Corresponding author. Mailing address: Department of Molecular Biology and Immunology, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107. Phone: (817) 735-2116. Fax: (817) 735-2118. E-mail: jsimecka{at}hsc.unt.edu.

Infection and Immunity, April 2001, p. 2328-2338, Vol. 69, No. 4
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.4.2328-2338.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • McCormick, S., Santosuosso, M., Small, C.-L., Shaler, C. R., Zhang, X., Jeyanathan, M., Mu, J., Takenaka, S., Ngai, P., Gauldie, J., Wan, Y., Xing, Z. (2008). Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs. J. Immunol. 181: 2356-2367 [Abstract] [Full Text]  
  • van Ginkel, F. W., Iwamoto, T., Schultz, B. D., Tomich, J. M. (2008). Immunity to a Self-Derived, Channel-Forming Peptide in the Respiratory Tract. CVI 15: 260-266 [Abstract] [Full Text]  
  • Wikstrom, M. E., Batanero, E., Smith, M., Thomas, J. A., von Garnier, C., Holt, P. G., Stumbles, P. A. (2006). Influence of Mucosal Adjuvants on Antigen Passage and CD4+ T Cell Activation during the Primary Response to Airborne Allergen. J. Immunol. 177: 913-924 [Abstract] [Full Text]  
  • Byrd, W., Cassels, F. J. (2006). The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration.. Microbiology 152: 779-786 [Abstract] [Full Text]  
  • Arnaboldi, P. M., Behr, M. J., Metzger, D. W. (2005). Mucosal B Cell Deficiency in IgA-/- Mice Abrogates the Development of Allergic Lung Inflammation. J. Immunol. 175: 1276-1285 [Abstract] [Full Text]  
  • Eriksson, A. M., Schon, K. M., Lycke, N. Y. (2004). The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues. J. Immunol. 173: 3310-3319 [Abstract] [Full Text]  
  • Woolard, M. D., Hodge, L. M., Jones, H. P., Schoeb, T. R., Simecka, J. W. (2004). The Upper and Lower Respiratory Tracts Differ in Their Requirement of IFN-{gamma} and IL-4 in Controlling Respiratory Mycoplasma Infection and Disease. J. Immunol. 172: 6875-6883 [Abstract] [Full Text]  
  • Guthrie, T., Wong, S. Y. C., Liang, B., Hyland, L., Hou, S., Hoiby, E. A., Andersen, S. R. (2004). Local and Systemic Antibody Responses in Mice Immunized Intranasally with Native and Detergent-Extracted Outer Membrane Vesicles from Neisseria meningitidis. Infect. Immun. 72: 2528-2537 [Abstract] [Full Text]  
  • Imai, Y., Nagai, R., Ono, Y., Ishikawa, T., Nakagami, H., Tanikawa, T., Kurohane, K. (2004). Production of Secretory Immunoglobulin A against Shiga Toxin-Binding Subunits in Mice by Mucosal Immunization. Infect. Immun. 72: 889-895 [Abstract] [Full Text]  
  • Sehra, S., Pynaert, G., Tournoy, K., Haegeman, A., Matthys, P., Tagawa, Y., Pauwels, R., Grooten, J. (2003). Airway IgG Counteracts Specific and Bystander Allergen-Triggered Pulmonary Inflammation by a Mechanism Dependent on Fc{gamma}R and IFN-{gamma}. J. Immunol. 171: 2080-2089 [Abstract] [Full Text]  
  • Anjuere, F., George-Chandy, A., Audant, F., Rousseau, D., Holmgren, J., Czerkinsky, C. (2003). Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses. J. Immunol. 170: 1586-1592 [Abstract] [Full Text]  
  • Liu, Z., Liu, Q., Pesce, J., Whitmire, J., Ekkens, M. J., Foster, A., VanNoy, J., Sharpe, A. H., Urban, J. F. Jr., Gause, W. C. (2002). Nippostrongylus brasiliensis Can Induce B7-Independent Antigen-Specific Development of IL-4-Producing T Cells from Naive CD4 T Cells In Vivo. J. Immunol. 169: 6959-6968 [Abstract] [Full Text]  
  • Jones, H. P., Hodge, L. M., Fujihashi, K., Kiyono, H., McGhee, J. R., Simecka, J. W. (2001). The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune Stimulation. J. Immunol. 167: 4518-4526 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»